StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $406.23MP/E –Yield –

Vireo Growth price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Vireo Growth's price to sales ratio was 0.7× on Oct 19, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.2× to 5.0×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.7×−1.1
2025Dec 31, 20251.7×+0.8
2024Dec 31, 20240.9×+0.5
2023Dec 29, 20230.4×+0.1
2022Dec 30, 20220.3×−3.5
2021Dec 31, 20213.8×–

More Vireo Growth figures

See a number that looks wrong?